ClinicalTrials.gg
Not yet recruitingNCT07348744KAU-BSE-RCTUpdated Jan 16, 2026

The Effect of a Health Belief Model-Based Education Program on Breast Self-Examination Practice Behavior, Breast Cancer Fear, and Awareness Levels in Women: A Randomized Controlled Trial

An interventional study of Health Belief Model-Based Education Program in Breast Self-Examination and Breast Cancer, sponsored by Kafkas University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 20 Years to 69 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-16.

Primary conditionBreast NeoplasmsRegistry: Breast Self-ExaminationReclassifiedWhy we changed it
Registry
Breast Self-Examination — the first condition term the registry derived for this study.
ClinicalTrials.gg
Breast Neoplasms
Why
  1. Breast Self-Examination is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Breast Neoplasms.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Kafkas University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
20 Years to 69 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 400 studies in Breast Neoplasms with a site in Turkey — 83 open to participants now, 129 under way, 46 of them phase 3. Breast Neoplasms · Turkey.

Planned enrollment
196th of 321
76 · median 100
Started
2026
with 39 others
No phase
184 of 400
48 open now
Primary completion
2026-06
later than 56 of 128 live
Registered
350th of 400
by date

Among the 400 studies in Breast Neoplasms with a site in Turkey, this one is the 196th largest by planned enrollment of the 321 interventional ones that give a count, is one of 40 that started in 2026, is one of 184 with no phase, reaches primary completion later than 56 of the 128 other live ones, and was the 350th registered.

Breast Neoplasms

14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.

Browse Breast Neoplasms studies →

Open to participants now

83 of the 400 studies in Breast Neoplasms with a site in Turkey are open now. Recruiting first, the newest first:

78 more — sign in →

All 83 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 2,403 Breast Neoplasms studies recruiting now, 1,574 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.

This study: 20 Years to 69 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 400 studies in Breast Neoplasms with a site in Turkey, or all of them as a file.
02

Study summary

The study titled "The Effect of a Health Belief Model-Based Training Program on Women's Self-Breast Examination Behavior, Breast Cancer Fear and Awareness Levels: A Randomized Controlled Study" aimed to increase breast cancer awareness and the application of breast self-examination techniques among women by providing the necessary training through a training program based on the Health Belief Model.

Read the detailed description

This randomized controlled study aims to evaluate the effectiveness of a Health Belief Model-based education program on women's breast self-examination practices, breast cancer fear, and awareness levels. Participants will be randomly assigned to either an intervention group receiving a structured education program based on the Health Belief Model or a control group receiving usual care.

Data will be collected using a Personal Information Form, the Champion Health Belief Model Scale, the Comprehensive Breast Cancer Knowledge Test, the Breast Cancer Awareness Scale, and the Champion Breast Cancer Fear Scale at baseline and three months after the intervention. The findings of this study are expected to contribute to the development of effective educational strategies for improving breast cancer awareness and preventive health behaviors among women.

03

Conditions studied

  • Breast Self-Examination
  • Breast Cancer

Browse trials for

Keywords

  • Breast Self-Examination
  • Breast Cancer
  • Health Belief Model
04

In context

Breast Neoplasms Reclassified

14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.

This study's planned enrollment of 76 is close to the median of 72 across 10,921 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Kafkas University is the lead sponsor of 32 studies on the registry; 11 are open to participants now.

Compared within Breast Neoplasms, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Breast Self-Examination. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
20 Years to 69 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being affiliated with Family Health Center No. 1 in Ardahan Province,
  • Being a woman between the ages of 20 and 69,
  • Being literate,
  • Not having been diagnosed with breast cancer,
  • Not having a mental or communication disorder,
  • Having a phone available for communication,
  • Women who voluntarily agree to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Difficulty communicating,
  • Wanting to drop out of the study,
  • Not wanting to participate in the study.
  • Women who did not fill out the data form despite reminders via message and phone call.
06

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
76 participants (estimated)

Study arms

  • Experimental
    Health Belief Model-Based Education Group

    Participants receive a structured education program based on the Health Belief Model focusing on breast self-examination.

    Behavioral: Health Belief Model-Based Education Program

  • No intervention
    Control Group

    Participants receive usual care without any additional educational intervention.

Interventions

  • BehavioralHealth Belief Model-Based Education Program

    A structured education program based on the Health Belief Model designed to improve breast self-examination behavior and increase breast cancer awareness.

07

What researchers measure

Primary outcomes

  1. Change in Breast Self-Examination Behavior

    Change in breast self-examination behavior measured as a single self-reported outcome indicating whether participants perform breast self-examination.

    Time frame: Baseline and 3 months after the intervention

Secondary outcomes

  1. Change in Breast Cancer Knowledge Level

    Change in breast cancer knowledge assessed using the Comprehensive Breast Cancer Knowledge Test.

    Time frame: Baseline and 3 months after the intervention

  2. Change in Breast Cancer Awareness Level

    Change in breast cancer awareness measured using the Breast Cancer Awareness Scale.

    Time frame: Baseline and 3 months after the intervention

  3. Change in Breast Cancer Fear Level

    Change in fear related to breast cancer measured using the Champion Breast Cancer Fear Scale.

    Time frame: Baseline and 3 months after the intervention

08

Study locations

1 site
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2026; primary completion for Jun 2026, 5 months later.

Of 2,673 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's planned 5 months is below that.

Counting every sponsor, half of 2,783 studies reached it within 33 months; a quarter within 15 and three quarters within 66.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 29, 2025
First posted
Jan 16, 2026
StartEst.
Jan 2026
Primary completionEst.
Jun 2026
CompletionEst.
Aug 2026
Last update
Jan 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07348744
Lead sponsor
Kafkas University
Responsible party
Cansu Karadağ (Principal Investigator, Kafkas University) — Principal investigator
First posted
Jan 16, 2026
Start date
Jan 2026 (estimated)
Primary completion
Jun 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Jan 16, 2026

Study contacts

CANSU KARADAĞ
Contact
cansukaradag@ardahan.edu.tr
05414233218
CANSU KARADAĞ
principal investigator · Kafkas University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion